{
  "docId": "019de071-1bdd-70bb-9c61-980d0c38b663",
  "docSlug": "a4792f18c57ea3f4ba27e696a63520de",
  "documentTitle": "AstraZeneca | Investor Day Presentation Deck | 40 slides",
  "authorId": "astrazeneca",
  "authorName": "AstraZeneca",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.4148858,
  "pageNumber": 16,
  "pageCount": 40,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "timeline",
  "function": "establish_context",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "The slide uses a timeline structure to demonstrate long-term innovation and market presence.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de071-1bdd-70bb-9c61-980d0c38b663/16",
  "deckHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663",
  "deckJsonHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663.json",
  "deckAnchorHref": "/decks/019de071-1bdd-70bb-9c61-980d0c38b663#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.66,
        "y": 0.65
      },
      "kind": "list",
      "text": "2020's: Enhertu - Transformative HER2-directed medicine that has started to redefine the way physicians classify and treat HER2-expressing breast cancer",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "11054cc9-c505-4180-8285-0a7aade62666",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.06,
        "y": 0.65
      },
      "kind": "list",
      "text": "2000's: Faslodex - The current endocrine therapy of choice in metastatic breast cancer",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89e47e55-3bd8-455e-9cc6-11a128ec1672",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.36,
        "y": 0.65
      },
      "kind": "list",
      "text": "2010's: Lynparza - First targeted treatment option for patients with BRCA-mutated breast cancer both in the metastatic and early breast cancer setting",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b079bba7-e379-48a4-b275-ac328818d678",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.06,
        "y": 0.31
      },
      "kind": "list",
      "text": "1970's: Nolvadex - On the World Health Organization's list of essential drugs for the treatment of breast cancer",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fa8cf9d4-0632-45f1-b944-e41b30ce9287",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.66,
        "y": 0.31
      },
      "kind": "list",
      "text": "1990's: Arimidex - One of the gold-standard medicines for postmenopausal HR+ breast cancer for years",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fb1e1102-aa4d-491b-8b1e-718c8d046ef8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.28,
        "x": 0.36,
        "y": 0.31
      },
      "kind": "list",
      "text": "1980's: Zoladex - Lutenising hormone-releasing agonist of choice for ovarian suppression in premenopausal women with breast cancer",
      "attrs": null,
      "subkind": "timeline-item",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "feee3f6b-ab2d-4f7e-9872-5640d0f3b998",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.9,
        "x": 0.05,
        "y": 0.14
      },
      "kind": "title",
      "text": "Breast cancer: AstraZeneca's pioneering medicines have helped patients for more than four decades",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "880514d7-1aa8-4861-aa69-27c99ffd59e8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "timeline",
      "slug": null,
      "matchId": "2e2f1f82-1d15-4743-9593-09d46954d9e3",
      "evidence": "Chronological presentation of products by decade",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 20,
      "from": 7,
      "beatId": "6407b6da-054c-43a3-924f-c8af0ea8759b",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The document showcases AstraZeneca's pipeline and progress in various areas of oncology, providing satisfaction to investors.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}